Immunex was acquired by Amgen on July 16, 2002
life science Company

Out of 60 sectors in the Mergr database, life science ranked 14 in number of deals in 2002. The largest life science acquisition in 2002 was Immunex - which was acquired by Amgen for $16.0B.

Join Mergr to view all 34 acquisitions of life science companies in 2002, including 10 acquisitions by private equity firms, and 24 by strategics.

Immunex Corp.

51 University Street,
Seattle, Washington 98101
United States,
(206) 587-0430

Immunex Corporation is a biopharmaceutical company dedicated to improving lives through immune system science innovation.

Life Science M&A - Last 3 Years

Immunex was acquired by Amgen on July 16, 2002.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Immunex.


What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.6K Private Equity Firms
  • 127K M&A Transactions
  • 136K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.9K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.